Director/PDMR Shareholding

RNS Number : 7658H

GlaxoSmithKline PLC

07 November 2008

 



Notification of Transactions of Directors, Persons Discharging 

Managerial Responsibility or Connected Persons

The administrators of the GlaxoSmithKline Performance Share Plan (the "Administrators") notified the Company and the under-mentioned persons on 7 November 2008 of an increase in their notional interests in Ordinary shares at a price of £11.66 per share and Ordinary Share ADRs at a price of $37.32 per ADR following the notional re-investment of the dividend to be paid to shareholders on 8 January 2009.

	Ordinary shares	ADRs
Mr A P Witty	5,625.13
Mr J S Heslop	3,959.53
Dr M M Slaoui	352.25	1,835.07
Mrs C E Bruck Slaoui	28.07	41.75
Mr S M Bicknell	296.63
Mr J M Clarke	2,952.21
Mr M Dunoyer	1,111.87
Mr E J Gray	921.57
Mr S A Hussain	545.32
Mr D Learmouth	607.10
Mr W C Louv		738.09
Mr D J Phelan		1,563.87
Dr D Pulman		1015.50
Mr D S Redfern	452.42
Mr J R Stéphenne	1,019.86
Ms C Thomas	340.46

The Administrators also notified the Company on 7 November 2008 of a further increase in the notional interests of the under-mentioned persons in Ordinary shares at a price of £11.67 following the notional re-investment of the dividend paid to shareholders on the 9 October 2008. 

	Ordinary shares
Mr A P Witty	690.66
Mr A S Hussain	500.36

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a). 

Victoria A Whyte

Deputy Company Secretary

7 November 2008

 

END

 

 

RDSDDLFBVFBEFBD